Compliance Certificate for the quarter ended 30.09.2025, as per SEBI(PIT) Regulations,2015.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has submitted a compliance certificate to the stock exchanges for the quarter ended 30 September 2025, as mandated under SEBI's Prohibition of Insider Trading (PIT) Regulations, 2015. The filing confirms that the company has maintained the required structured digital database of designated persons/insiders and adhered to insider trading rules during the quarter. The certificate is typically signed by the Compliance Officer. This is a routine, mandatory regulatory submission with no financial or business figures attached.
No material impact on shareholders or stock price. This is a standard procedural compliance filing required of all listed companies and does not signal any positive or negative development.